Falls in Parkinson's disease. Causes and impact on patients' quality of life

Functional Neurology

Volumn 20, Issue 4, 2005, Pages 163-168

  Michałowska, Małgorzata ^a   Fiszer, Urszula ^a   Krygowska Wajs, Anna ^b   Owczarek, Krzysztof ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Falls; Parkinson's disease; Quality of life

Indexed keywords

AMANTADINE; BROMOCRIPTINE; LEVODOPA; PERGOLIDE; SELEGILINE;

ADULT; AGED; ARTICLE; BODY POSTURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE DURATION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; FALL RISK ASSESSMENT; FALLING; FEMALE; FREEZING TOLERANCE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PREVALENCE; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; VASOMOTOR REFLEX;

ACCIDENTAL FALLS; ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; COGNITION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; HYPOTENSION, ORTHOSTATIC; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; SEX CHARACTERISTICS;

EID: 33645072987     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ashburn A, Stack E, Pickering RM, Ward CD. A community-dwelling sample with Parkinson's disease: characteristics of fallers and non-fallers. Age Ageing 2001;30:3-4
2. Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol 2001;248:950-958
3. Gray P, Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs 2000;32:222-228
4. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721-725
5. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology 2001;56(Suppl 5):S1-S88
6. Michałowska M, Krygowska-Wajs A, Jedynecka U, Sobieszek A, Fiszer U. Analysis of the cause of falls in patients with Parkinson's disease. Neurol Neurochir Pol 2002; 36:57-68
7. Fife D, Barancik JI, Chatterjee MS. Northeastern Ohio Trauma Study, II: injury rates by age, sex and cause. Am J Public Health 1984;74:473-478
8. Grisso A Kelsey JL, Strom BL et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991; 324:1326-1331
9. Kellogg International Work Group on the Prevention of Falls in the Elderly. The prevention of falls in later life. Dan Med Bull 1987;34(Suppl 4):1-24
10. O'Loughlin J, Robitaille Y, Boivin J, Suissa S. Incidence of risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol 1993:342-354
11. Tinetti ME, Speechley M, Ginter SF. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988;319:1701-1707
12. King MB, Tinetti ME. Falls in community-dwelling older persons. J Am Geriatr Soc 1995;43:1146-1154
13. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:431-435
14. Hobson P, Holden A, Meara J. Measuring the impact of Parkinson's disease with the Parkinson Disease Quality of Life questionnaire. Age Ageing 1999;28:341-346
15. Kuopio AM, Martilla RJ, Helenius H, Toivonen M, Rinne UK. The quality of life in Parkinson's disease. Mov Disord 2000;15:216-233
16. Schrag A, Jahanshabi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312
17. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-67
18. Oertel WH, Quinn NP. Parkinsonism. Movement Disorders. Neurological Disorders: Course and Treatment. American Press 1996:715-772
19. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's. J Neuropathol Appl Neurobiol 1990;15:27-44
20. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-249
21. Stacy M, Jankovic J. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes. Neurol Clin 1992;10:341-359
22. Wenning GK, Ben-Shlomo Y, Magalhaes M et al. Clinico-pathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166
23. Litvan I, Mangone CA, McKee A et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Ol-szewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996:615-620
24. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP. What clinical features are most useful to distinguish multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;68:434-440
25. Hoehn MM, Yahr DM. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442
26. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Mardsen CD, Caine DB et al. eds Recent Developments in Parkinson's Disease. Florhan Park, NJ; MacMillan Health Care Information 1987:153-163
27. Folstein MF, Folstein SE, McHugh P. Mini-Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 1975;12:189-198
28. Bödeker K. Angiopathien. In: Braun J, Renz U, Schäffler A eds Klinikleitfaden. Stuttgart; Jugjohann Verlagsgeselischaft mgH, Neckarsulm, 1991:161.
29. Jenkinson C, Fitzpatrick R, Peto V. The Parkinson's disease questionnaire. User manual for the PDQ-39, PDQ-8 and PDQ Summary Index. Oxford; Health Services Research Unit 1998:45-50
30. 123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53: 1020-1025
31. 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 1999;40:371-375
32. Soikkeli R, Partanen J, Soininen H, Pääkkönen A, Riekkinven Sr. A. Slowing of EEG in Parkinson's disease. Electroencephalogr Clin Neurophysiol 1991;79:159-169